COPPER BINDING OF COMMERCIAL, NORMAL RECOMBINANT, & MUTANT HUMAN SERUM ALBUMINS

商业、正常重组的铜结合，

• 批准号: 6118864
• 负责人: KRISHNA HAROHALLI
• 金额: $ 0.24万
• 依托单位: MEDICAL COLLEGE OF WISCONSIN
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-03-01 至 2000-02-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6118864
• 关键词: bioengineering /biomedical engineering; biological products; biomaterials; biomedical resource; proteins

Commercial serum albumin, bovine serum albumin, normal reconstituted serum albumin, and two mutants of serum albumin were titrated with copper(II) to study weaker copper binding sites. Preliminary experiments were done in July and follow-up titrations were completed in November.

市售血清白蛋白，牛血清白蛋白，正常 重组血清白蛋白，和两个突变体的血清白蛋白， 用铜（II）滴定以研究较弱的铜结合位点。 初步实验在7月完成， 已于11月完成。